NANOBIOTIX SA

مادة اعلانية

Latest Update: 23 Dec 2024 20:30 Abu Dhabi Time.

Market Status: Opened

NANO

NANOBIOTIX SA

5.63

EUR

-3.910

-40.99%

Open

5.63

Prev Close

5.63

PX_VOLUME

MARKET CAP (M)

DAY RANGE

5.63 - 5.63

52 WEEKS

2.67 - 7.93

Stock Statistics

Yearly Change

-49.58%

Listed Shares (Million)

Earnings Multiple

Average 30-day trading volume

Price-to-book ratio

Earnings Per Share

-1.08

Previous Dividend Distribution

Dividend Yield

0.00%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2023	Sep 30, 2023	Mar 30, 2023	Jun 30, 2024	Mar 31, 2024	Jun 30, 2023
Total Revenue		30.06	30.06	0.00	6.16	0.00	0.00
Gross Profit		30.06	30.06	0.00
Operating Income		-3.74	-3.74	-26.97
Net Income		-11.60	-11.60	-28.10
Profit Margin		-38.60	-38.60

	Period Ending:	Dec 31, 2023	Dec 31, 2022
Total Revenue	30.06	0.00
Gross Profit	30.06	0.00
Operating Income	-30.72	-50.79
Net Income	-39.70	-57.04
Profit Margin	-132.08

Balance Sheet

	Period Ending:	Sep 30, 2023	Mar 30, 2023	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Jun 30, 2023
Total Assets		93.90	40.41
Total Liabilities		95.74	94.19
Total Equity		-1.84	-53.78

	Period Ending:	Dec 31, 2023	Dec 31, 2022
Total Assets	93.90	59.77
Total Liabilities	95.74	86.81
Total Equity	-1.84	-27.04

Cash Flows Statements

	Period Ending:	Jun 30, 2024	Mar 30, 2024	Dec 31, 2023	Sep 30, 2023
Cash From Operating Activities		-6.44	-6.44	-1.77	-1.77
Cash From Investing Activities		-0.50	-0.50	-0.02	-0.02
Cash From Financing Activities		-2.05	-2.05	55.48	55.48
Net Change in Cash		-8.95	-8.95	53.65	53.65

	Period Ending:	Dec 31, 2023	Dec 31, 2022
Cash From Operating Activities	-19.45	-38.02
Cash From Investing Activities	-0.35	0.14
Cash From Financing Activities	53.75	-4.74
Net Change in Cash	33.90	-42.53

* In Million of Euro Member Countries

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.